From Covid-19 booster shots to the T-Mobile hack, this is how stocks were effected by the week's news
starting this fall for adults who were fully vaccinated with the two-shot regimen from Pfizer and partner BioNTech SE or from Moderna Inc. The booster shot will be administered about eight months after the second dose, starting the week of Sept. 20. Pfizer shares fell 2.2% Wednesday, while Moderna lost 0.8%.as more people returned to stores to purchase apparel, food and other items.
Online spending abated at the big-box retailer compared with last summer, when the pandemic upended shopping habits. The report came a day after larger rival Walmart Inc. reported strong in-store sales and foot traffic. The results from both chains showed little impact from the recent rise in Covid-19 cases in the U.S. Target executives said that the Delta variant’s spread hasn’t yet resulted in changes to consumer behavior, but they are closely monitoring the situation. Target shares fell 2.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Full FDA approval of Pfizer/BioNTech Covid-19 vaccine is 'imminent, senior federal official saysJUST IN: Full FDA approval of the Pfizer/BioNTech Covid-19 vaccine is 'imminent,' a senior official says, and 'could be as early as Monday,' according to a Biden official
Consulte Mais informação »
Pfizer Covid-19 Vaccine Expected to Get Full FDA Approval Next WeekThe FDA is expected to grant full approval of Pfizer's Covid-19 vaccine next week. The two-dose shot was first cleared in December by the agency on an emergency use basis.
Consulte Mais informação »
Pfizer COVID-19 vaccine poised to get full FDA approval next week, source saysThe U.S. Food and Drug Administration full approval of the Pfizer coronavirus vaccine will likely will come on Monday or Tuesday, according to one official familiar with the plans.
Consulte Mais informação »
As Covid-19 Boosters Loom, Pfizer and Moderna Expected to See Billions More in SalesVaccine makers Pfizer and Moderna are on track to notch billions more in sales than previously expected, as new booster-shot strategies and concerns about the Delta variant push demand, and the companies raise prices in the U.S. and elsewhere
Consulte Mais informação »
Pfizer Expects To Apply For Emergency Use Authorization For Kid Vaccine By SeptemberPfizer Expects To Apply For Emergency Use Authorization For Kid Vaccine By September “Pfizer expects to have enough data by the end of next month to support emergency use authorization for kids ages 6 and older to receive the vaccine.”
Consulte Mais informação »
Pfizer COVID-19 vaccine poised to get full FDA approval next week, source saysThe U.S. Food and Drug Administration full approval of the Pfizer coronavirus vaccine will likely will come on Monday or Tuesday, according to one official familiar with the plans.
Consulte Mais informação »